scholarly journals Auditory verbal hallucinations in first-episode psychosis: a phenomenological investigation

BJPsych Open ◽  
2016 ◽  
Vol 2 (1) ◽  
pp. 88-95 ◽  
Author(s):  
Rachel Upthegrove ◽  
Jonathan Ives ◽  
Matthew R. Broome ◽  
Kimberly Caldwell ◽  
Stephen J. Wood ◽  
...  
Keyword(s):  
Mental Illness ◽  
Subjective Experience ◽  
Phenomenological Study ◽  
First Episode Psychosis ◽  
Photo Elicitation ◽  
First Episode ◽  
Primary Research ◽  
Auditory Verbal Hallucinations ◽  
Episode Psychosis ◽  
Living Being

BackgroundIn dimensional understanding of psychosis, auditory verbal hallucinations (AVH) are unitary phenomena present on a continuum from non-clinical voice hearing to severe mental illness. There is mixed evidence for this approach and a relative absence of research into subjective experience of AVH in early psychosis.AimsTo conduct primary research into the nature of subjective experience of AVH in first-episode psychosis.MethodA phenomenological study using diary and photo-elicitation qualitative techniques investigating the subjective experience of AVH in 25 young people with first-episode psychosis.ResultsAVH are characterised by: (a) entity, as though from a living being with complex social interchange; and (b) control, exerting authority with ability to influence. AVH are also received with passivity, often accompanied by sensation in other modalities.ConclusionsA modern detailed phenomenological investigation, without presupposition, gives results that echo known descriptive psychopathology. However, novel findings also emerge that may be features of AVH in psychosis not currently captured with standardised measures.

What Is Psychosis?

2021 ◽  
pp. 3-16
Author(s):  
Beth Broussard ◽  
Michael T. Compton
Keyword(s):  
Mental Illness ◽  
Young People ◽  
First Episode Psychosis ◽  
Initial Evaluation ◽  
Treatment Programs ◽  
First Episode ◽  
Her Family ◽  
Episode Psychosis ◽  
The Individual ◽  
Work Goals

This first chapter explains what psychosis is. Psychosis is a treatable mental illness. For many people with first-episode psychosis, symptoms begin to clear up partially or completely within weeks of starting treatment. Although the symptoms of psychosis may be frightening to the individual and his or her family, there are treatments for these symptoms. First-episode psychosis is the period of time when a person first begins to experience psychosis. It is during this time that young people and their families need detailed information about the initial evaluation and treatment. People who get into treatment earlier often do better. In many places, specialty treatment programs now exist that specifically focus on first-episode psychosis. Those programs often provide treatments designed to help young people get back on track in terms of school and work goals.

scholarly journals Glucose metabolism dysregulation at the onset of mental illness is not limited to first episode psychosis: A systematic review and meta‐analysis

2018 ◽  
Vol 13 (5) ◽  
pp. 1021-1031 ◽  
Author(s):  
Suat Kucukgoncu ◽  
Urska Kosir ◽  
Elton Zhou ◽  
Erin Sullivan ◽  
Vinod H. Srihari ◽  
...  
Keyword(s):  
Systematic Review ◽  
Mental Illness ◽  
Glucose Metabolism ◽  
Meta Analysis ◽  
First Episode Psychosis ◽  
First Episode ◽  
Episode Psychosis

scholarly journals Oral health experiences and needs among young adults after a first-episode psychosis : a phenomenological study

2018 ◽  
Vol 25 (8) ◽  
pp. 475-485 ◽  
Author(s):  
Sonja Kuipers ◽  
Stynke Castelein ◽  
Aaltsje Malda ◽  
Linda Kronenberg ◽  
Nynke Boonstra
Keyword(s):  
Young Adults ◽  
Oral Health ◽  
Phenomenological Study ◽  
First Episode Psychosis ◽  
First Episode ◽  
Episode Psychosis ◽  
Health Experiences

scholarly journals A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis

2016 ◽  
Vol 115 (11) ◽  
pp. 1987-1993 ◽  
Author(s):  
Scott B. Teasdale ◽  
Philip B. Ward ◽  
Simon Rosenbaum ◽  
Andrew Watkins ◽  
Jackie Curtis ◽  
...  
Keyword(s):  
Mental Illness ◽  
Severe Mental Illness ◽  
Diet Quality ◽  
Dietary Intervention ◽  
Vegetable Intake ◽  
First Episode Psychosis ◽  
Nutrition Intervention ◽  
Cardiometabolic Disease ◽  
First Episode ◽  
Episode Psychosis

AbstractSevere mental illness is characterised by a 20-year mortality gap due to cardiometabolic disease. Poor diet in those with severe mental illness is an important and modifiable risk factor. The present study aimed to (i) examine baseline nutritional intake in youth with first-episode psychosis (FEP), (ii) evaluate the feasibility and acceptability of nutritional intervention early in FEP and (iii) to evaluate the effectiveness of early dietary intervention on key nutritional end points. Participants were recruited over a 12-month period from a community-based programme specifically targeting young people aged 15–25 years with newly diagnosed FEP. Individual dietetic consultations and practical group sessions were offered as part of a broader lifestyle programme. Dietary assessments were conducted before and at the end of the 12-week intervention. Participants exceeded recommended energy and Na intakes at baseline. Retention within the nutrition intervention was 67 %, consistent with other interventions offered to FEP clients. There was a 47 % reduction in discretionary food intake (−94 g/d,P<0·001) and reductions in daily energy (−24 %,P<0·001) and Na (−26 %,P<0·001) intakes. Diet quality significantly improved, and the mean change was 3·6 (95 % CI 0·2, 6·9,P<0·05), although this finding was not significant after Bonferroni’s correction. Increased vegetable intake was the main factor contributing to improved diet quality. Nutrition intervention delivered shortly after initiation of antipsychotic medication is feasible, acceptable and effective in youth with FEP. Strategies to prevent weight gain and metabolic decline will contribute to prevent premature cardiometabolic disease in this vulnerable population.

scholarly journals Aberrant salience network functional connectivity in auditory verbal hallucinations: a first episode psychosis sample

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Pavan Kumar Mallikarjun ◽  
Paris Alexandros Lalousis ◽  
Thomas Frederick Dunne ◽  
Kareen Heinze ◽  
Renate LEP Reniers ◽  
...  
Keyword(s):  
Functional Connectivity ◽  
First Episode Psychosis ◽  
First Episode ◽  
Salience Network ◽  
Auditory Verbal Hallucinations ◽  
Episode Psychosis ◽  
Aberrant Salience

scholarly journals Liraglutide and the management of overweight and obesity in people with severe mental illness: qualitative sub-study

2022 ◽  
Vol 22 (1) ◽  
Author(s):  
Katharine Barnard-Kelly ◽  
Clare A. Whicher ◽  
Hermione C. Price ◽  
Peter Phiri ◽  
Shanaya Rathod ◽  
...  
Keyword(s):  
Mental Illness ◽  
Severe Mental Illness ◽  
Healthcare Professionals ◽  
First Episode Psychosis ◽  
First Episode ◽  
Schizoaffective Disorders ◽  
Episode Psychosis ◽  
Treatment Of Obesity

Abstract Background People with severe mental illness are two to three times more likely to be overweight or have obesity than the general population and this is associated with significant morbidity and premature mortality. Liraglutide 3 mg is a once daily injectable GLP-1 receptor agonist that is licensed for the treatment of obesity in the general population and has the potential to be used in people with severe mental illness. Aims To record the expectations and experiences of people with schizophrenia, schizoaffective disorders or first episode psychosis taking daily liraglutide 3 mg injections in a clinical trial for the treatment of obesity. To seek the views of healthcare professionals about the feasibility of delivering the intervention in routine care. Methods Qualitative interviews were undertaken with a purposive sub-sample of people with schizophrenia, schizoaffective disorders or first episode psychosis with overweight or obesity who were treated with a daily injection of liraglutide 3 mg in a double-blinded, randomised controlled pilot study evaluating the use of liraglutide for the treatment of obesity. Interviews were also conducted with healthcare professionals. Results Seventeen patient participants were interviewed. Sixteen took part in the baseline interview, eight completed both baseline and follow-up interviews, and one took part in follow-up interview only. Mean interview duration was thirteen minutes (range 5-37 min). Despite reservations by some participants about the injections before the study, most of those who completed the trial reported no challenges in the timing of or administering the injections. Key themes included despondency regarding prior medication associated weight gain, quality of life impact of weight loss, practical aspects of participation including materials received and clinic attendance. Healthcare professionals reported challenges with recruitment, however, overall it was a positive experience for them and for participants. Conclusion Liraglutide appears to be an acceptable therapy for obesity in this population with limited side effects. The quality of life benefits realised by several intervention participants reinforce the biomedical benefits of achieved weight loss.

scholarly journals F154. ABERRANT SALIENCE NETWORK FUNCTIONAL CONNECTIVITY IN AUDITORY VERBAL HALLUCINATIONS: A FIRST EPISODE PSYCHOSIS SAMPLE

2018 ◽  
Vol 44 (suppl_1) ◽  
pp. S280-S280
Author(s):  
Paris Alexandros Lalousis ◽  
Pavan Mallikarjun ◽  
Thomas Frederick Dunne ◽  
Kareen Heinze ◽  
Renate Reniers ◽  
...  
Keyword(s):  
Functional Connectivity ◽  
First Episode Psychosis ◽  
First Episode ◽  
Salience Network ◽  
Auditory Verbal Hallucinations ◽  
Episode Psychosis ◽  
Aberrant Salience
Sign in / Sign up

Export Citation Format

Share Document